Sri Lanka vs Turkmenistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Sri Lanka
0.3%
in 2024
Turkmenistan
0.3%
in 2024
Sri Lanka rank
85th
Turkmenistan rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Sri Lanka
- Turkmenistan
How they compare
Sri Lanka currently reports 0.3% against 0.3% in Turkmenistan, a difference of 0.0%.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Sri Lanka ranks 85th and Turkmenistan ranks 85th of 246 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Turkmenistan |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Sri Lanka or Turkmenistan?
- Sri Lanka, at 0.3% against 0.3% in Turkmenistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Sri Lanka and Turkmenistan?
- 0.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Sri Lanka and Turkmenistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Sri Lanka ranks 85th and Turkmenistan ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.